bullish
Hutchison-China Meditech Placement: Catalysts to Expect but Keep Overhang in Mind
467 Views22 Jan 2020 18:02
HCM, a leading China biotech company, filed a prospectus to sell USD 110 million of ADS. We have covered the company's fundamentals for its Hong...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (9 Feb 2020) - Mr. DIY, Kingsoft Cloud, SBI Cards, CAMS, Equitas SFB, Akeso Bio09 Feb 2020
- ECM Weekly (2 Feb 2020) - Smoore, Innocare, Kilcoy Global, Mr. DIY02 Feb 2020
- ECM Weekly (26 Jan 2020) - Central Retail Corp, Smoore, Mindspace Biz Parks REIT, Elite Comm REIT26 Jan 2020
- Hutchison-China Meditech Placement: Catalysts to Expect but Keep Overhang in Mind22 Jan 2020
- Hutchison-China Meditech (和黄医药) Placement: Big Discount After HK Listing Delayed28 Jun 2019
- Hutchison-China Meditech (和黄医药) H-Share Listing: MNC Partnerships Endorsed Its R&D Capabilities25 Apr 2019
x